Table of Contents Author Guidelines Submit a Manuscript
International Journal of Reproductive Medicine
Volume 2014 (2014), Article ID 218769, 11 pages
http://dx.doi.org/10.1155/2014/218769
Clinical Study

Impact of Exogenous Gonadotropin Stimulation on Circulatory and Follicular Fluid Cytokine Profiles

1The Leeds Centre for Reproductive Medicine, Leeds Teaching Hospitals NHS Trust, Seacroft Hospital, York Road, LS14 6UH Leeds, UK
2Women’s Health Research Group, Leeds Institute of Cancer & Pathology, St James’s University Hospital, Wellcome Trust Brenner Building, Beckett Street, LS9 7TF Leeds, UK

Received 23 September 2014; Accepted 11 November 2014; Published 30 November 2014

Academic Editor: Stefania A. Nottola

Copyright © 2014 N. Ellissa Baskind et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Pelinck, A. Hoek, A. H. M. Simons, and M. J. Heineman, “Efficacy of natural cycle IVF: a review of the literature,” Human Reproduction Update, vol. 8, no. 2, pp. 129–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Rosen, S. Shen, A. T. Dobson, P. F. Rinaudo, C. E. McCulloch, and M. I. Cedars, “A quantitative assessment of follicle size on oocyte developmental competence,” Fertility and Sterility, vol. 90, no. 3, pp. 684–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. X. Y. Wang, “The past, present, and future of embryo selection in in vitro fertilization: frontiers in reproduction conference,” The Yale Journal of Biology and Medicine, vol. 84, no. 4, pp. 487–490, 2011. View at Google Scholar · View at Scopus
  4. N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser, “The science behind 25 years of ovarian stimulation for in vitro fertilization,” Endocrine Reviews, vol. 27, no. 2, pp. 170–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Geraedts and L. Gianaroli, “Embryo selection and IVF,” Human Reproduction, vol. 27, no. 9, pp. 2876–2877, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. H. Y. Ng, E. Y. L. Lau, W. S. B. Yeung, and P. C. Ho, “Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment,” Journal of Assisted Reproduction and Genetics, vol. 20, no. 5, pp. 186–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Sharma, J. Williams, W. Collins, A. Riddle, B. Mason, and M. Whitehead, “A comparison of treatments with exogenous FSH to promote folliculogenesis in patients with quiescent ovaries due to the continued administration of an LH-RH agonist,” Human Reproduction, vol. 2, no. 7, pp. 553–556, 1987. View at Google Scholar · View at Scopus
  8. V. Sharma, M. Whitehead, B. Mason et al., “Influence of superovulation on endometrial and embryonic development,” Fertility and Sterility, vol. 53, no. 5, pp. 822–829, 1990. View at Google Scholar · View at Scopus
  9. J. A. Horcajadas, A. Riesewijk, J. Polman et al., “Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles,” Molecular Human Reproduction, vol. 11, no. 3, pp. 195–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. E. B. Baart, E. Martini, M. J. Eijkemans et al., “Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial,” Human Reproduction, vol. 22, no. 4, pp. 980–988, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Horcajadas, P. Díaz-Gimeno, A. Pellicer, and C. Simón, “Uterine receptivity and the ramifications of ovarian stimulation on endometrial function,” Seminars in Reproductive Medicine, vol. 25, no. 6, pp. 454–460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Horcajadas, P. Mínguez, J. Dopazo et al., “Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4500–4510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Santos, E. W. Kuijk, and N. S. Macklon, “The impact of ovarian stimulation for IVF on the developing embryo,” Reproduction, vol. 139, no. 1, pp. 23–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Pellicer, A. Ruiz, R. M. Castellvi et al., “Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?” Human Reproduction, vol. 4, no. 5, pp. 536–540, 1989. View at Google Scholar · View at Scopus
  15. M. H. van der Gaast, M. J. C. Eijkemans, J. B. van der Net et al., “Optimum number of oocytes for a successful first IVF treatment cycle,” Reproductive BioMedicine Online, vol. 13, pp. 476–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Aboulghar, A. M. Ramzy, R. T. Mansour, Y. M. Amin, and G. I. Serour, “Oocyte quality in patients with severe ovarian hyperstimulation syndrome,” Fertility and Sterility, vol. 68, no. 6, pp. 1017–1021, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Ertzeid and R. Storeng, “Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice,” Journal of Reproduction and Fertility, vol. 96, no. 2, pp. 649–655, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Van Der Auwera and T. D'Hooghe, “Superovulation of female mice delays embryonic and fetal development,” Human Reproduction, vol. 16, no. 6, pp. 1237–1243, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Hodges, A. Ilagan, D. Jennings, R. Keri, J. Nilson, and P. A. Hunt, “Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation,” Human Reproduction, vol. 17, no. 5, pp. 1171–1180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Li, H.-L. Feng, Y.-J. Cao et al., “Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro,” Fertility and Sterility, vol. 85, no. 4, pp. 827–832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Von Wolff, Z. Kollmann, C. E. Flück et al., “Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF,” Human Reproduction, vol. 29, no. 5, pp. 1049–1057, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. N. Andersen, P. Devroey, and J.-C. Arce, “Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial,” Human Reproduction, vol. 21, no. 12, pp. 3217–3227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Weghofer, S. Munné, W. Brannath et al., “The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: antagonist cycles,” Fertility and Sterility, vol. 92, no. 3, pp. 937–942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Regan, E. J. Owen, and H. S. Jacobs, “Hypersecretion of luteinising hormone, infertility, and miscarriage,” The Lancet, vol. 336, no. 8724, pp. 1141–1144, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. J. N. Hugues, J. Soussis, I. Calderon et al., “Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study,” Human Reproduction, vol. 20, no. 3, pp. 629–635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Shoham, “The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation,” Fertility and Sterility, vol. 77, no. 6, pp. 1170–1177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Schimberni, F. Morgia, J. Colabianchi et al., “Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles,” Fertility and Sterility, vol. 92, no. 4, pp. 1297–1301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-G. Nygren, “Single embryo transfer: the role of natural cycle/minimal stimulation IVF in the future,” Reproductive BioMedicine Online, vol. 14, no. 5, article 2841, 2007. View at Google Scholar · View at Scopus
  29. R. Cutting, D. Morroll, S. Roberts, S. Pickering, and A. Rutherford, “Elective single embryo transfer: guidelines for practice British fertility society and association of clinical embryologists,” Human Fertility, vol. 11, no. 3, pp. 131–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Joint SOGC-CFAS, “Guidelines for the number of embryos to transfer following in vitro fertilization no. 182, September 2006,” International Journal of Gynecology & Obstetrics, vol. 102, pp. 203–216, 2008. View at Publisher · View at Google Scholar
  31. J. D. Gordon, M. Dimattina, A. Reh, A. Botes, G. Celia, and M. Payson, “Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database,” Fertility and Sterility, vol. 100, no. 2, pp. 392–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. C. Fauser, G. Nargund, A. N. Andersen et al., “Mild ovarian stimulation for IVF: 10 years later,” Human Reproduction, vol. 25, no. 11, pp. 2678–2684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Nargund, B. C. J. M. Fauser, N. Macklon, W. Ombelet, K. Nygren, and R. Frydman, “The ISMAAR proposal on terminology for ovarian stimulation for IVF,” Human Reproduction, vol. 22, no. 11, pp. 2801–2804, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. W. M. Enien, S. El Sahwy, C. P. Harris, M. W. Seif, and M. Elstein, “Human chorionic gonadotrophin and steroid concentrations in follicular fluid: the relationship to oocyte maturity and fertilization rates in stimulated and natural in-vitro fertilization cycles,” Human Reproduction, vol. 10, no. 11, pp. 2840–2844, 1995. View at Google Scholar · View at Scopus
  35. M. J. De Los Santos, V. Garca-Lez, D. Beltrn-Torregrosa et al., “Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles,” Human Reproduction, vol. 27, no. 6, pp. 1596–1605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Vinatier, C. Lefebvre-Maunoury, and C. Bernardi, “The ovaries, the immune system, cytokines: physiology,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 22, no. 6, pp. 581–591, 1993. View at Google Scholar · View at Scopus
  37. C. L. Best and J. A. Hill, “Interleukin-1α and -β modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis,” Human Reproduction, vol. 10, no. 12, pp. 3206–3210, 1995. View at Google Scholar · View at Scopus
  38. V. Machelon and D. Emilie, “Production of ovarian cytokines and their role in ovulation in the mammalian ovary,” European Cytokine Network, vol. 8, no. 2, pp. 137–143, 1997. View at Google Scholar · View at Scopus
  39. D. F. Albertini, C. M. H. Combelles, E. Benecchi, and M. J. Carabatsos, “Cellular basis for paracrine regulation of ovarian follicle development,” Reproduction, vol. 121, no. 5, pp. 647–653, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Eppig, “Oocyte control of ovarian follicular development and function in mammals,” Reproduction, vol. 122, no. 6, pp. 829–838, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. K. Skinner, “Regulation of primordial follicle assembly and development,” Human Reproduction Update, vol. 11, no. 5, pp. 461–471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Vujisić, S. Ž. Lepej, I. Emedi, R. Bauman, A. Remenar, and M. K. Tiljak, “Ovarian follicular concentration of IL-12, IL-15, IL-18 and p40 subunit of IL-12 and IL-23,” Human Reproduction, vol. 21, no. 10, pp. 2650–2655, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Vujisic and S. Zidovec, “Follicular immunology environment and the influence on in-vitro fertilization outcome,” Current Women's Health Reviews, vol. 1, pp. 49–60, 2005. View at Google Scholar
  44. C. Mendoza, N. Cremades, E. Ruiz-Requena et al., “Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations,” Human Reproduction, vol. 14, no. 3, pp. 628–635, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. M. E. Hammadeh, A. K. Ertan, M. Baltes et al., “Immunoglobulins and cytokines level in follicular fluid in relation to etiology of infertility and their relevance to IVF outcome,” American Journal of Reproductive Immunology, vol. 47, no. 2, pp. 82–90, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Mendoza, E. Ruiz-Requena, E. Ortega et al., “Follicular fluid markers of oocyte developmental potential,” Human Reproduction, vol. 17, no. 4, pp. 1017–1022, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. M. E. Hammadeh, C. Fischer-Hammadeh, A. S. Amer, P. Rosenbaum, and W. Schmidt, “Relationship between cytokine concentration in serum and preovulatory follicular fluid and in vitro fertilization/intracytoplasmic sperm injection outcome,” Chemical Immunology and Allergy, vol. 88, pp. 80–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Bedaiwy, A. Y. Shahin, A. M. AbulHassan et al., “Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles,” Reproductive BioMedicine Online, vol. 15, no. 3, pp. 321–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Lédée, R. Lombroso, L. Lombardelli et al., “Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor,” Human Reproduction, vol. 23, no. 9, pp. 2001–2009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Revelli, L. D. Piane, S. Casano, E. Molinari, M. Massobrio, and P. Rinaudo, “Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics,” Reproductive Biology and Endocrinology, vol. 7, article 40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Lédée, M. Petitbarat, M. Rahmati et al., “New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side,” Journal of Reproductive Immunology, vol. 88, no. 2, pp. 118–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Sarapik, A. Velthut, K. Haller-Kikkatalo et al., “Follicular proinflammatory cytokines and chemokines as markers of IVF success,” Clinical and Developmental Immunology, vol. 2012, Article ID 606459, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Hagberg, C. Mallard, and B. Jacobsson, “Role of cytokines in preterm labour and brain injury,” British Journal of Obstetrics and Gynaecology, vol. 112, supplement 1, pp. 16–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Agic, H. Xu, D. Finas, C. Banz, K. Diedrich, and D. Hornung, “Is endometriosis associated with systemic subclinical inflammation?” Gynecologic and Obstetric Investigation, vol. 62, no. 3, pp. 139–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. O. B. Christiansen, H. S. Nielsen, and A. M. Kolte, “Inflammation and miscarriage,” Seminars in Fetal and Neonatal Medicine, vol. 11, no. 5, pp. 302–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Arici, E. Oral, O. Bukulmez, S. Buradagunta, O. Engin, and D. L. Olive, “Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells,” Endocrinology, vol. 137, no. 9, pp. 3762–3769, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Runesson, K. Ivarsson, P. O. Janson, and M. Brännström, “Gonadotropin- and cytokin-regulated expression of the chemokine interleukin 8 in the human preovulatory follicle of the menstrual cycle,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4387–4395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Baud and M. Karin, “Signal transduction by tumor necrosis factor and its relatives,” Trends in Cell Biology, vol. 11, no. 9, pp. 372–377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. R. P. Numerof and K. Asadullah, “Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis,” BioDrugs, vol. 20, no. 2, pp. 93–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Weiser, J. Miu, H. J. Ball, and N. H. Hunt, “Interferon-γ synergises with tumour necrosis factor and lymphotoxin-α to enhance the mRNA and protein expression of adhesion molecules in mouse brain endothelial cells,” Cytokine, vol. 37, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. N. A. Bersinger, Z. Kollmann, and M. von Wolff, “Serum but not follicular fluid cytokine levels are increased in stimulated versus natural cycle IVF: a multiplexed assay study,” Journal of Reproductive Immunology, vol. 106, pp. 27–33, 2014. View at Publisher · View at Google Scholar
  62. O. Tokuyama, Y. Nakamura, A. Muso, Y. Fujino, O. Ishiko, and S. Ogita, “Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle,” Journal of Assisted Reproduction and Genetics, vol. 19, no. 1, pp. 19–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. J. S. Cunha-Filho, N. Lemos, N. Stein, A. Laranjeira, and E. P. Passos, “Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist,” Fertility and Sterility, vol. 83, no. 4, pp. 902–907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. C. McRae, N. E. Baskind, N. M. Orsi, V. Sharma, and J. Fisher, “Metabolic profiling of follicular fluid and plasma from natural cycle in vitro fertilization patients—a pilot study,” Fertility and Sterility, vol. 98, no. 6, pp. 1449.e6–1457.e6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. N. M. Orsi, N. Gopichandran, U. V. Ekbote, and J. J. Walker, “Murine serum cytokines throughout the estrous cycle, pregnancy and post partum period,” Animal Reproduction Science, vol. 96, no. 1-2, pp. 54–65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. P. F. Levay, C. Huyser, F. L. Fourie, and D. J. Rossouw, “The detection of blood contamination in human follicular fluid,” Journal of Assisted Reproduction and Genetics, vol. 14, no. 4, pp. 212–217, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Huyser, F. L. R. Fourie, and L. Wolmarans, “Spectrophotometric absorbance of follicular fluid: a selection criterion,” Journal of Assisted Reproduction and Genetics, vol. 9, no. 6, pp. 539–544, 1992. View at Publisher · View at Google Scholar · View at Scopus
  68. C. M. Boomsma, A. Kavelaars, M. J. C. Eijkemans, B. C. J. M. Fauser, C. J. Heijnen, and N. S. MacKlon, “Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo,” Fertility and Sterility, vol. 94, no. 5, pp. 1764–1768, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. R. L. de Mola, J. M. Goldfarb, B. R. Hecht, G. P. Baumgardner, C. J. Babbo, and M. A. Friedlander, “Gonadotropins induce the release of interleukin-1β, interleukin-6 and tumor necrosis factor-α from the human preovulatory follicle,” American Journal of Reproductive Immunology, vol. 39, no. 6, pp. 387–390, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. de Los Santos, V. Garca-Lez, D. Beltrn-Torregrosa et al., “Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles,” Human Reproduction, vol. 27, no. 6, pp. 1596–1605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Arici, E. Oral, O. Bahtiyar, O. Engin, E. Seli, and E. E. Jones, “Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells,” Human Reproduction, vol. 12, no. 6, pp. 1233–1239, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Coskun, M. Uzumcu, K. Jaroudi, J. M. G. Hollanders, R. S. Parhar, and S. T. Al-Sedairy, “Presence of leukemia inhibitory factor and interleukin-12 in human follicular fluid during follicular growth,” The American Journal of Reproductive Immunology, vol. 40, no. 1, pp. 13–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Jean, S. Mirallie, P. Barriere et al., “Leukaemia inhibitory factor expression in human follicular fluid,” Human Reproduction, vol. 14, no. 2, article 571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Zhao, J. E. Nichols, S. E. Bulun, C. R. Mendelson, and E. R. Simpson, “Aromatase P450 gene expression in human adipose tissue: role of a Jak/STAT pathway in regulation of the adipose-specific promoter,” The Journal of Biological Chemistry, vol. 270, no. 27, pp. 16449–16457, 1995. View at Publisher · View at Google Scholar · View at Scopus
  75. O. Bukulmez and A. Arici, “Leukocytes in ovarian function,” Human Reproduction Update, vol. 6, no. 1, pp. 1–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. K. C. Reinhart, R. K. Dubey, C. L. Mummery, M. Van Rooijen, P. J. Keller, and R. Marinella, “Synthesis and regulation of leukaemia inhibitory factor in cultured bovine oviduct cells by hormones,” Molecular Human Reproduction, vol. 4, no. 3, pp. 301–308, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. J. E. Holt, A. Jackson, S. D. Roman, R. J. Aitken, P. Koopman, and E. A. McLaughlin, “CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary,” Developmental Biology, vol. 293, no. 2, pp. 449–460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Nishigaki, H. Okada, R. Okamoto et al., “Concentrations of stromal cell-derived factor-1 and vascular endothelial growth factor in relation to the diameter of human follicles,” Fertility and Sterility, vol. 95, no. 2, pp. 742–746, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Hamza, J. B. Barnett, and B. Li, “Interleukin 12 a key immunoregulatory cytokine in infection applications,” International Journal of Molecular Sciences, vol. 11, no. 3, pp. 789–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Trinchieri, “Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity,” Annual Review of Immunology, vol. 13, pp. 251–276, 1995. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Hodge-Dufour, M. W. Marino, M. R. Horton et al., “Inhibition of interferon γ induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13806–13811, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Giuliani, W. Schoell, J. Auner, and W. Urdl, “Controlled ovarian hyperstimulation in assisted reproduction: effect on the immune system,” Fertility and Sterility, vol. 70, no. 5, pp. 831–815, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Hoek, J. Schoemaker, and H. A. Drexhage, “Premature ovarian failure and ovarian autoimmunity,” Endocrine Reviews, vol. 18, no. 1, pp. 107–134, 1997. View at Publisher · View at Google Scholar · View at Scopus